The great trade rearrangement
McKensey
JUNE 24, 2025
If they cannot, firms might instead reduce purchases, replace imported products with something similar, or ramp up domestic production. It is lowest for pharmaceutical products (roughly 0.03), midrange (between 0.3 At a glance Amid pressure on USâChina trade, firms may look to rearrange sourcing to alternative suppliers.
Let's personalize your content